Veterinary Medicines

Gallivac IB88 Neo Bruistablet voor vernevelsuspensie

Authorised
  • Avian infectious bronchitis virus, type 793/B, strain CR88121, Inactivated
Download as PDF

Product identification

Medicine name:
Gallivac IB88 Neo Bruistablet voor vernevelsuspensie
Gallivac IB88 Neo Comprimé effervescent pour suspension pour inhalation par nébuliseur
Gallivac IB88 Neo Brausetablette zur Herstellung einer Suspension für einen Vernebler
Active substance:
  • Avian infectious bronchitis virus, type 793/B, strain CR88121, Inactivated
Target species:
  • Poultry
Route of administration:
  • Nebulisation use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, type 793/B, strain CR88121, Inactivated
    4.00
    log 10 50% embryo infective dose
    /
    1.00
    Other
Pharmaceutical form:
  • Effervescent tablet
Withdrawal period by route of administration:
  • Nebulisation use
    • Poultry
      • Meat and offal
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Gallivac IB88 Neo 100 2000 doses Effervescent tablets for nebuliser suspension in blister of 10 tablets
  • Gallivac IB88 Neo 10 2000 doses Effervescent tablets for nebuliser suspension in blister of 10 tablets
  • Gallivac IB88 Neo 100 1000 doses Effervescent tablets for nebuliser suspension in blister of 10 tablets
  • Gallivac IB88 Neo 10 1000 doses Effervescent tablets for nebuliser suspension in blister of 10 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V502986
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 21/03/2022
Download
French (PDF)
Published on: 21/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 21/03/2022
Download
French (PDF)
Published on: 21/03/2022
Download
German (PDF)
Published on: 21/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."